高级搜索
徐海涛, 张连国, 刘建伟, 刘洪建, 张庆广. 贲门癌中巨噬细胞移动抑制因子表达与患者临床病理特征及预后的关系[J]. 肿瘤防治研究, 2016, 43(9): 779-782. DOI: 10.3971/j.issn.1000-8578.2016.09.010
引用本文: 徐海涛, 张连国, 刘建伟, 刘洪建, 张庆广. 贲门癌中巨噬细胞移动抑制因子表达与患者临床病理特征及预后的关系[J]. 肿瘤防治研究, 2016, 43(9): 779-782. DOI: 10.3971/j.issn.1000-8578.2016.09.010
XU Haitao, ZHANG Lianguo, LIU Jianwei, LIU Hongjian, ZHANG Qingguang. Relationship of Macrophage Migration Inhibitory Factor Expression with Clinicopathologic Features and Prognosis of Cardiac Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 779-782. DOI: 10.3971/j.issn.1000-8578.2016.09.010
Citation: XU Haitao, ZHANG Lianguo, LIU Jianwei, LIU Hongjian, ZHANG Qingguang. Relationship of Macrophage Migration Inhibitory Factor Expression with Clinicopathologic Features and Prognosis of Cardiac Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 779-782. DOI: 10.3971/j.issn.1000-8578.2016.09.010

贲门癌中巨噬细胞移动抑制因子表达与患者临床病理特征及预后的关系

Relationship of Macrophage Migration Inhibitory Factor Expression with Clinicopathologic Features and Prognosis of Cardiac Carcinoma Patients

  • 摘要:
    目的  探讨巨噬细胞移动抑制因子(macrophage migration inhibitory factor, MIF)在贲门癌中的表达及其与患者临床病理特征和预后的关系。
    方法  选取滨州医学院附属医院胸外科2008年1月—2009年12月经胸手术切除的贲门癌石蜡标本73例,采用免疫组织化学法检测贲门癌组织中MIF的表达水平,根据免疫反应强弱将其分为高表达组和低表达组,分析MIF表达水平与患者临床病理特征的关系,Kaplan-Meier生存曲线比较MIF高表达组和低表达组患者的生存期,Cox回归模型分析MIF的表达水平与临床病理特征及患者预后的关系。
    结果  MIF在贲门癌组织中高表达42例,高表达率为57.5%。MIF表达水平与患者的年龄、性别、肿瘤分化程度、淋巴结转移和TNM分期无关(P>0.05),与肿瘤的浸润深度有关(P=0.025)。MIF高表达组和低表达组的生存期用Kaplan-Meier方法评估,并用Log rank检验进行比较,两组之间生存率差异有统计学意义(P=0.001)。多因素Cox回归模型分析表明,淋巴结转移(P=0.025)、MIF表达水平(P=0.001)是影响贲门癌预后的独立危险因素。
    结论  MIF的表达异常可能在贲门癌的浸润及预后中有重要作用,对患者预后的判断有一定指导意义。

     

    Abstract:
    Objective  To investigate the expression of macrophage migration inhibitory factor (MIF) in cardiac carcinoma and its correlation with clinicopathologic features and prognosis.
    Methods  The paraffin specimens from 73 patients with cardiac carcinoma who underwent thoracotomy were collected from the Affiliated Hospital of Binzhou Medical University from 2008-01-03 to 2009-12-31. The expressions of MIF in 73 specimens of cardiac carcinoma were assessed by immunohistochemistry. Based on the levels of MIF immunoreactivities, the 73 specimens were divided into high MIF expression group and low MIF expression group, and the correlations of MIF expression with clinicopathologic features was analyzed. Kaplan-Meier survival curves were used to compare the survival between high MIF expression group and low MIF expression group. The correlations of MIF expression with clinicopathologic features and the prognosis of cardiac carcinoma patients were analyzed by Cox regression model.
    Results  The high MIF expression rate was 57.5%. There was no significant correlation between the levels of MIF expression and age, gender, tumor differentiation, lymph node metastasis, TNM stages(P>0.05). However, the high MIF expression was strongly correlated with the depth of invasion(P=0.025). The survival rates were significantly different between the two groups(P=0.001). The multivariate Cox regression model analysis showed that lymph node metastasis(P=0.025) and the levels of MIF expression(P=0.001) were the independent prognostic risk factors for cardiac carcinoma.
    Conclusion  The abnormal of MIF expression in cardiac carci noma may play an important role in tumor infiltration and prognosis. MIF could be a valuable prognostic factor for the patients with cardiac carcinoma.

     

/

返回文章
返回